Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis

J Trone; J Ollier; C. Chapelle; J Bertoletti; E Cucherat; J Mismetti; E Magné; J Laporte

doi:10.1093/annonc/mdy035

Journal articles

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis

J Trone J Ollier C. Chapelle ¹ J Bertoletti E Cucherat J Mismetti E Magné J Laporte

1 GRT (EA 3065) - Groupe de recherche sur la thrombose

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Pharmaceutical sciences / Pharmacology

Complete list of metadatas

https://hal-hcl.archives-ouvertes.fr/hal-02112951
Contributor : Michel Cucherat <>
Submitted on : Saturday, April 27, 2019 - 1:11:58 PM
Last modification on : Monday, August 31, 2020 - 9:52:06 AM

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis

Links full text

Identifiers

Collections

Citation

Export

Metrics

51

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

51